Products intended for animals follow specific rules. Here are the points to check before making any decision for an animal.
PRACTICAL GUIDE
Dogs, cats and other animals also have an endocannabinoid system. This has drawn the attention of owners, researchers and veterinarians to CBD. Oils, treats, topical products and veterinary formulations have multiplied in some markets.
Precision matters: a dog is not a small human. Sensitivity varies greatly between species, and not all human products suit animals.
The endocannabinoid system functions in many mammals. As human CBD research expanded, questions naturally arose about its potential veterinary value.
Age-related joint pain, travel stress, recovery and chronic illness are common reasons owners cite. Veterinary studies have also developed around these themes.
Pilot studies tested CBD formulations in dogs with osteoarthritis. Some found changes in pain or mobility scores, but studies remain limited and use precisely standardised products.
CBD has also been studied as an adjunct in canine epilepsy protocols. Results attract interest, but larger studies are needed on response profiles, doses and interactions.
Studies on anxiety, stress and reactivity are more heterogeneous. Transport, separation, loud noises and new surroundings trigger different responses, and protocols vary widely.
Two CBD oils can have very different compositions. In animals, THC, concentration, carrier oil and other ingredients require particular attention.
Human products may contain flavourings, sweeteners or excipients unsuitable for animals. Veterinary formulations and professional advice therefore matter.
Weight is only one factor. Age, liver function, current treatments, the condition and individual sensitivity can completely change product assessment.
Some studies monitor drowsiness, digestive problems and behavioural changes. Tolerability varies with formulation and quantity.
There is more evidence for dogs than cats. Cats have a different metabolism and fewer clinical studies. Findings in dogs should not automatically be transferred to cats.
Growing owner interest led laboratories, universities and manufacturers to develop animal-specific formulations. This provides more pharmacokinetic data than a few years ago.
This specialisation is especially interesting: rather than transferring human products, veterinary research examines species-specific doses, tolerability and formulations.
Animals, especially dogs, can be sensitive to THC. Accidental cannabis poisoning occurs and can cause neurological or digestive signs.
Yes, especially in dogs, on osteoarthritis, epilepsy, pharmacokinetics and tolerability.
No. Composition, concentration and excipients can differ. That is why veterinary advice is useful.
Also read our article on cannabinoids to better understand CBD, THC, CBG and CBN.
Your selection awaits
Find our two main collections quickly or browse the whole shop.
